Commodore Capital LP - 03 Apr 2025 SCHEDULE 13G Report for Celldex Therapeutics, Inc. Common Stock, par value $.001 (CLDX)

Filing Manager
Commodore Capital LP
Reporting Manager
COMMODORE CAPITAL LP
Security
Celldex Therapeutics, Inc. Common Stock, par value $.001
Symbol
CLDX
Shares outstanding
67M shares
Disclosed Ownership
3.35M shares
Ownership
5%
Form type
SCHEDULE 13G
Filing time
10 Apr 2025, 16:05:05 UTC
Date of event
03 Apr 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
COMMODORE CAPITAL LP 5% 3.35M 0 3.35M /s/ Michael Kramarz Michael Kramarz, Managing Partner
Commodore Capital Master LP 5% 3.35M 0 3.35M /s/ Michael Kramarz Michael Kramarz, Authorized Signatory